亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Anaplastic Large Cell Lymphoma With Intraocular or Ocular Adnexal Involvement: A Case Report and Systematic Review

医学 间变性大细胞淋巴瘤 布仑妥昔单抗维多汀 CD30 淋巴瘤 间变性淋巴瘤激酶 外科 皮肤病科 内科学 恶性胸腔积液 胸腔积液
作者
Seyed Mohsen Rafizadeh,Hossein Ghahvehchian,Mohammad Taher Rajabi,Mostafa Heidari,Elaham Rahmanikhah
出处
期刊:Ophthalmic Plastic and Reconstructive Surgery [Lippincott Williams & Wilkins]
标识
DOI:10.1097/iop.0000000000002520
摘要

To review the existing literature on patients with anaplastic large cell lymphoma (ALCL) affecting the globe and/or ocular adnexa, and to present a report documenting the clinical course of a patient with ALCL that involved their globe and ocular adnexa.PubMed, Scopus, and Google scholar were systematically searched for all cases of ALCL involving intraocular or adnexal ocular structures from inception to May 2023. Moreover, a new reported case added to the cases found in searches.The review identified 1680 studies, with 8 meeting inclusion criteria. A total of 9 patients were included with a mean age of 29.7 years (median: 30.0, range: 1.3-48). Primary ALCL was present in 5/9 (55.6%) patients. The most common ophthalmic manifestations included periorbital swelling (5/8), chemosis (5.8), and decreased vision (5/7). Misdiagnoses were initially made in 3 patients, and the lag time to correct diagnosis from 3 weeks to 3 months. CD30 expression was positive in all cases, and 6/9 patients were positive for anaplastic lymphoma kinase, resulting in 6/9 patients being diagnosed with anaplastic lymphoma kinase-positive ALCL. In terms of management modalities, chemotherapy was administered in 8/9 patients, while radiation therapy was utilized in 4/9 patients, and 2 underwent autologous stem cell transplantation. Five (55.6%) patients succumbed to ALCL while 4 (44.4%) were alive and disease-free at the last follow-up. The median times from the initial presentation of ALCL to death, ophthalmic presentation to death, and diagnosis to death were 4.12 months (range: 1.1-168.0), 2.62 months (range: 1.1-144), and 4.00 months (range: 0.10-168), respectively. The median follow-up duration was 21.0 months (range: 1.1-168.0).ALCL involving the globe and ocular adnexa is a rare and highly malignant tumor that can mimic benign clinical conditions. Early biopsy and aggressive treatment with chemotherapy regimens such as CHOP and radiation therapy may be useful.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
科研通AI2S应助科研通管家采纳,获得10
7秒前
科研通AI2S应助科研通管家采纳,获得10
7秒前
科研通AI5应助大胆盼兰采纳,获得50
14秒前
23秒前
mila完成签到,获得积分10
35秒前
思源应助mila采纳,获得10
43秒前
56秒前
1分钟前
1分钟前
mila发布了新的文献求助10
1分钟前
Getlogger发布了新的文献求助10
1分钟前
yema完成签到 ,获得积分10
1分钟前
Orange应助青山采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
CodeCraft应助田一采纳,获得10
1分钟前
nebula发布了新的文献求助10
1分钟前
1分钟前
木马上市完成签到,获得积分10
2分钟前
青山发布了新的文献求助10
2分钟前
执着的怜珊完成签到,获得积分10
2分钟前
stevenliu67完成签到,获得积分10
2分钟前
共享精神应助科研通管家采纳,获得10
2分钟前
ding应助执着的怜珊采纳,获得10
2分钟前
2分钟前
星星完成签到,获得积分10
2分钟前
甜美的秋尽完成签到,获得积分10
2分钟前
火星上胜完成签到 ,获得积分10
3分钟前
lvlv完成签到,获得积分10
3分钟前
科研通AI2S应助科研通管家采纳,获得10
4分钟前
4分钟前
冷傲语风发布了新的文献求助10
4分钟前
CipherSage应助青山采纳,获得10
4分钟前
乐乐应助冷傲语风采纳,获得10
4分钟前
舒萼完成签到,获得积分10
4分钟前
conanyangqun完成签到,获得积分10
4分钟前
5分钟前
5分钟前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
CRC Handbook of Chemistry and Physics 104th edition 1000
Izeltabart tapatansine - AdisInsight 600
An International System for Human Cytogenomic Nomenclature (2024) 500
Introduction to Comparative Public Administration Administrative Systems and Reforms in Europe, Third Edition 3rd edition 500
Distinct Aggregation Behaviors and Rheological Responses of Two Terminally Functionalized Polyisoprenes with Different Quadruple Hydrogen Bonding Motifs 450
China—Art—Modernity: A Critical Introduction to Chinese Visual Expression from the Beginning of the Twentieth Century to the Present Day 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3767074
求助须知:如何正确求助?哪些是违规求助? 3311548
关于积分的说明 10158852
捐赠科研通 3026748
什么是DOI,文献DOI怎么找? 1661316
邀请新用户注册赠送积分活动 793951
科研通“疑难数据库(出版商)”最低求助积分说明 755878